TABLE 4

Sensitivity, with Equivocal Lesions Considered Either Positive or Negative for Metastases in 2 Separate Analyses, for 18F-DCFBC PET and CIM as Estimated by GEE Regression Model Analysis

ModalitySensitivity (equivocal lesions considered negative)Sensitivity (equivocal lesions considered positive)
18F-DCFBC PET0.92 (0.80–0.97)0.88 (0.70–0.96)
CECT0.64 (0.41–0.82)0.77 (0.58–0.89)
BS0.40 (0.20–0.65)0.43 (0.25–0.63)
CIM (BS and CECT)0.71 (0.49–0.86)0.82 (0.60–0.93)
  • Data in parentheses are 95% CIs.